Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- Check7 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No substantive study details appear to have changed.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor software version update with no observable changes to the study details.SummaryDifference0.1%

- Check50 days agoChange DetectedGlossary is now shown on the page; update metadata now includes 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3 with no changes to study content or essential features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedLocations section updated to include Guangdong and Hubei locations; revision noted as v3.3.3.SummaryDifference0.4%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.